Cellebrite DI Ltd. reported earnings of $ 0.11 per CLBT share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | $ 0.09404 |
| Earnings Per Share (Surprise) | $ 0.11 (+$ 0.01596) |
| Last Year's EPS | $ 0.09667 |
| EPS YoY Change |
Out of the last 27 earnings reporting periods, Cellebrite DI Ltd. beat analysts’ expectations 13 times and fell short of expectations 7 time(s). Cellebrite DI Ltd. reported earnings per share of $ 0.11 in the last report surpassing an estimated EPS of $ 0.09404 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | $ 0.09404 | $ 0.11 | $ 0.08 | |
| Aug 13, 2026 | $ 0.05939 | $ 0.0257 | $ 0.12 | |
| May 14, 2026 | $ 0.05377 | $ 0.04 | $ 0.10 | |
| Feb 11, 2026 | $ 0.14 | $ 0.0867 | $ 0.10 | |
| Nov 12, 2025 | $ 0.09449 | $ 0.08 | $ 0.14 | |
| Aug 14, 2025 | $ 0.10 | $ 0.12 | $ 0.10 | |
| May 14, 2025 | $ 0.05254 | $ 0.10 | $ 0.08 | |
| Feb 13, 2025 | $ 0.10 | $ 0.10 | $ 0.11 | |
| Nov 6, 2024 | $ 0.09 | $ 0.14 | $ 0.10 | |
| Aug 15, 2024 | $ 0.05 | $ 0.10 | $ 0.05 | |
| May 23, 2024 | $ 0.06 | $ 0.08 | $ 0.03 | |
| Feb 15, 2024 | $ 0.06 | $ 0.11 | $ 0.08 | |
| Nov 14, 2023 | $ 0.05 | $ 0.10 | $ 0.01 | |
| Aug 8, 2023 | $ 0.02 | $ 0.05 | $ 0.17 | |
| May 10, 2023 | $ 0.03 | $ 0.03 | $ 0.01 | |
| Feb 15, 2023 | $ 0.04 | $ 0.08 | $ 0.03 | |
| Nov 17, 2022 | $ 0.02 | $ 0.01 | $ 0.08 | |
| Aug 11, 2022 | $ 0.03 | $ 0.17 | $ 0.0435 | |
| May 12, 2022 | $ 0.02 | $ 0.01 | $ 0.0192 | |
| Feb 16, 2022 | $ 0.02 | $ 0.03 | $ 0.01578 |
Cellebrite DI Ltd.’s stock was trading at $ 12.70 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, CLBT’s price decreased to $ 11.53 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | $ 0.11 | $ 12.70 | $ 11.53 | |
| Aug 13, 2026 | $ 0.0257 | $ 15.25 | $ 11.14 | |
| May 14, 2026 | $ 0.04 | $ 12.10 | $ 12.98 | |
| Feb 11, 2026 | $ 0.0867 | $ 14.94 | $ 13.70 | |
| Nov 12, 2025 | $ 0.08 | $ 15.70 | $ 19.28 | |
| Aug 14, 2025 | $ 0.12 | $ 13.99 | $ 15.60 | |
| May 14, 2025 | $ 0.10 | $ 20.12 | $ 17.27 | |
| Feb 13, 2025 | $ 0.10 | $ 24.92 | $ 20.50 | |
| Nov 6, 2024 | $ 0.14 | $ 19.15 | $ 18.79 | |
| Aug 15, 2024 | $ 0.10 | $ 13.94 | $ 16.44 | |
| May 23, 2024 | $ 0.08 | $ 11.61 | $ 11.10 | |
| Feb 15, 2024 | $ 0.11 | $ 9.68 | $ 11.39 | |
| Nov 14, 2023 | $ 0.10 | $ 7.54 | $ 8.00 | |
| Aug 8, 2023 | $ 0.05 | $ 7.37 | $ 7.99 | |
| May 10, 2023 | $ 0.03 | $ 5.75 | $ 5.61 | |
| Feb 15, 2023 | $ 0.08 | $ 5.18 | $ 5.95 | |
| Nov 17, 2022 | $ 0.01 | $ 4.91 | $ 4.62 | |
| Aug 11, 2022 | $ 0.17 | $ 5.67 | $ 5.34 | |
| May 12, 2022 | $ 0.01 | $ 4.73 | $ 5.16 | |
| Feb 16, 2022 | $ 0.03 | $ 7.01 | $ 7.45 |
Cellebrite DI Ltd. released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Cellebrite DI Ltd. beat analysts’ expectations during the last earnings period by
